Discovery of LY2607540: A novel and selective mGluR2 positive allosteric modulator (PAM) demonstrates activity in animal models of anxiety and depression

被引:0
|
作者
Khilevich, Albert [1 ]
Mayhugh, Daniel R. [1 ]
Hay, David A. [1 ]
Zhang, Deyi [1 ]
Liu, Bin [1 ]
Svensson, Kjell A. [1 ]
Falcone, Julie F. [1 ]
Heinz, Beverly A. [1 ]
Wang, Xushan [1 ]
Witkin, Jeff M. [1 ]
Rassmussen, Kurt [1 ]
Rorick-Kehn, Linda [1 ]
Benvenga, Mark J. [1 ]
Li, Xia [1 ]
Hart, John C. [1 ]
Chaney, Stephen [1 ]
Catlow, John T. [1 ]
Swanson, Steve [1 ]
Schkeryantz, Jeffrey M. [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
87-MEDI
引用
收藏
页数:1
相关论文
共 31 条
  • [31] Discovery of (S)-2-Cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): A Novel, CNS Penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) Positive Allosteric Modulator (PAM)
    Morris, Lindsey C.
    Nance, Kellie D.
    Gentry, Patrick R.
    Days, Emily L.
    Weaver, C. David
    Niswender, Colleen M.
    Thompson, Analisa D.
    Jones, Carrie K.
    Locuson, Chuck W.
    Morrison, Ryan D.
    Daniels, J. Scott
    Niswender, Kevin D.
    Lindsley, Craig W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (23) : 10192 - 10197